I think Tuesday is more likely than Friday. In general the government agencies have the freedom to round days. As long as we get priority, I don’t even care if it comes in 2 weeks.
However, I think if we don’t hear by end of next week, there could be back ground BO chatter. Remember, we don’t even know the certain date the whole file transfer was completed, plus what’s amarin or anyone going to do to the fda if they go a couple days over?
As long as there is no bad news, I think we can assume things are scheduled as planned and going well.
Side question- has there ever been a bid for a one drug company over 15billion? Or 10bil? Some analysts I was talking to were saying we’ve become a bit too expensive of a buyout for a one drug company with no other drugs in pipeline. Just wondering what others would have been comparable
News 
Market Data 
Discover 
AI
